MDMA Therapy for PTSD Rejected by FDA Panel – Shocking New Findings Revealed!
MIAMI, FL – The use of MDMA for the treatment of PTSD has been met with skepticism after an FDA panel rejected its approval. The decision comes after a series of trials showcasing the potential benefits of the psychedelic drug in therapy. The FDA advisory panel’s rejection of the use of MDMA marks a setback for researchers and advocates who have been touting its potential to revolutionize the treatment of PTSD. Despite promising results from …